Barry H Dash insider trades: Elite Pharmaceuticals (ELTP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Barry reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | ELTP | ↑ Buy | 100,000 | $0.26 | $26K | Direct | Oct 19, 2026 (10d) |
| Feb 3, 2011 | ELTP | ↑ Buy | 340,954 | $0.04 | $14K | Direct | Mar 16, 2011 (41d) |
| Nov 17, 2008 | GORX | ↑ Buy | 5,000 | $0.46 | $2K | Direct | Nov 18, 2008 (1d) |
| Jul 3, 2006 | ELI | ↑ Buy | 7,000 | $2.37 | $17K | Direct | May 21, 2007 (322d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Barry H Dash's insider trades
Barry H Dash is a director at Elite Pharmaceuticals (ELTP). Since Jul 3, 2006, Barry has reported 4 open-market purchases worth $59K and no sales on SEC Form 4. In the last 12 months: 1 buy ($26K).
Their filings also include grants and awards (17 filings), conversions (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELTP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.